GB1545411A - P-biphenylyl esters of 15-peteroaryl-16,17,18,19,20-pentanorprostaglandins - Google Patents

P-biphenylyl esters of 15-peteroaryl-16,17,18,19,20-pentanorprostaglandins

Info

Publication number
GB1545411A
GB1545411A GB35750/77A GB3575077A GB1545411A GB 1545411 A GB1545411 A GB 1545411A GB 35750/77 A GB35750/77 A GB 35750/77A GB 3575077 A GB3575077 A GB 3575077A GB 1545411 A GB1545411 A GB 1545411A
Authority
GB
United Kingdom
Prior art keywords
peteroaryl
pentanorprostaglandins
biphenylyl
esters
biphenylyl esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB35750/77A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of GB1545411A publication Critical patent/GB1545411A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
GB35750/77A 1976-08-27 1977-08-25 P-biphenylyl esters of 15-peteroaryl-16,17,18,19,20-pentanorprostaglandins Expired GB1545411A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71813876A 1976-08-27 1976-08-27

Publications (1)

Publication Number Publication Date
GB1545411A true GB1545411A (en) 1979-05-10

Family

ID=24884966

Family Applications (1)

Application Number Title Priority Date Filing Date
GB35750/77A Expired GB1545411A (en) 1976-08-27 1977-08-25 P-biphenylyl esters of 15-peteroaryl-16,17,18,19,20-pentanorprostaglandins

Country Status (9)

Country Link
JP (1) JPS5328160A (en)
BE (1) BE858146A (en)
DE (1) DE2737807A1 (en)
DK (1) DK379277A (en)
FR (1) FR2362848A1 (en)
GB (1) GB1545411A (en)
IE (1) IE45965B1 (en)
LU (1) LU78021A1 (en)
NL (1) NL7709386A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE43372E1 (en) 1999-03-05 2012-05-08 Duke University C16 unsaturated FP-selective prostaglandins analogs
US8541466B2 (en) 2000-03-31 2013-09-24 Duke University Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US8618086B2 (en) 2000-03-31 2013-12-31 Duke University Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US9346837B2 (en) 2000-03-31 2016-05-24 Duke University Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR204816A1 (en) * 1972-11-08 1976-03-05 Pfizer PROCEDURE TO PREPARE A PROSTAGLANDIN
GB1482010A (en) * 1974-10-28 1977-08-03 Ono Pharmaceutical Co Prostaglandin analogues

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE43372E1 (en) 1999-03-05 2012-05-08 Duke University C16 unsaturated FP-selective prostaglandins analogs
US8541466B2 (en) 2000-03-31 2013-09-24 Duke University Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US8618086B2 (en) 2000-03-31 2013-12-31 Duke University Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US8906962B2 (en) 2000-03-31 2014-12-09 Duke University Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US9346837B2 (en) 2000-03-31 2016-05-24 Duke University Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US9579270B2 (en) 2000-03-31 2017-02-28 Duke University Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US9675539B2 (en) 2000-03-31 2017-06-13 Duke University Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins

Also Published As

Publication number Publication date
IE45965B1 (en) 1983-01-12
FR2362848B1 (en) 1980-07-11
DE2737807A1 (en) 1978-03-09
FR2362848A1 (en) 1978-03-24
BE858146A (en) 1978-02-27
LU78021A1 (en) 1979-05-23
JPS5328160A (en) 1978-03-16
IE45965L (en) 1978-02-27
DK379277A (en) 1978-02-28
NL7709386A (en) 1978-03-01

Similar Documents

Publication Publication Date Title
NZ183050A (en) Prostaglandin derivatives
JPS5384942A (en) Prostaglandin analogue
GB1538842A (en) Prostaglandin derivatives
JPS5555161A (en) Intermediate for manufacture of 1*55disubstitutedd22pyrrolidones
JPS52113947A (en) Prostaglandin derivatives
JPS57136577A (en) Manufacture of 2,4-diamino-5-benzylpyrimidine
JPS5337676A (en) Production of 22*44 aloylpiperazinee11yl**44aminoo 6*77dimethoxyquinazolines
GB1545411A (en) P-biphenylyl esters of 15-peteroaryl-16,17,18,19,20-pentanorprostaglandins
JPS52122691A (en) Production of 33 carbamoyloxymethylcephalosporin
AU2985577A (en) N-chloroacetyl-n-phenyl-alanine esters
JPS5359658A (en) Production of 33 acylaminoazetidinee22 one
IL53667A0 (en) The production of monochlorodiamino-s-triazines
JPS5350173A (en) Production of 2*33 cycloalkenopyridine
JPS52108974A (en) Production of triazolethiol
JPS52102260A (en) Production of 1133 triisubstitutedd33 phenylindanes
IL52194A (en) Production of 0,0-dialkyl-phosphorochloridothionates
JPS532454A (en) Esters of 55methyll10*111dihydroprostaglandinna1
JPS52108971A (en) Production of 33aminoo1*22 benzoisothiazol
JPS5346987A (en) Production of n 11*2** furanidyl**55fluorouracil
PT67412A (en) Esters
ZA776737B (en) Novel esters
JPS5315400A (en) Production of 133 hydroxybelbines
JPS5350147A (en) Production of 22methll 1*44naphthoquinone
JPS5331700A (en) Production of *binkamenine*
GB1532163A (en) Esters of isoxysuprine

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee